Mostrando 3 resultados de: 3
Subtipo de publicación
Article(3)
Área temáticas
Enfermedades(2)
Microorganismos, hongos y algas(2)
Farmacología y terapéutica(1)
Medicina y salud(1)
Origen
scopus(3)
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
ArticleAbstract: Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in thePalabras claves:antibody, B cell, BNT162b2, covid-19, dosing interval, Neutralization, SARS-COV-2, T cell, Vaccine, variants of concernAutores:Abuelgasim H., Adele S., Adland E., Adlou S., Akther H.D., Al-Taei S., Alhussni A., Ali M., Altmann T., Amini A., Angyal A., Arancibia-Cárcamo C.V., Austin J.A., Azim Ansari M., Barnes E., Bayley M., Bridges-Webb A., Brown A., Brown H., Brown R., Carroll M.W., Chalk J., Chand M., Chawla A., Chinnakannan S., Conlon C.P., Cross A., Cutteridge J., de Lara C., de Silva T.I., Deeks A.S., Dejnirattisai W., Denly L., Diffey B., Dimitriadis S., Dobson S.L., Dold C., Donnison T., Drake T.M., Dunachie S.J., Duncan C.J.A., Dupont M., Eyre D.W., Fairman A., Faustini S., Foulkes S., Frater J., Gardiner S., Gillson N., Goulder P., Hackstein C.P., Hall V., Hambleton S., Haniffa M., Hargreaves A., Haworth J., Hering L.M., Holmes J., Hopkins S., Horner E., Hornsby H., Jämsén A., Javier Gilbert Jaramillo, Jeffery K., Johnson S.A., Jones C., Kasanyinga M., Kelly S., Kilby J.A., Kirk R., Klenerman P., Knight M.L., Lawrie A., Lee L., Linder A., Longet S., Malone T., Matthews P.C., Meardon N., Mongkolsapaya J., Moore S.C., Nicols A.R., Payne R.P., Phillips E., Pollard A.J., Reyes L.S., Richter A., Rowland-Jones S.L., Saei A., Sandhar G., Screaton G.R., Shields A., Skelly D.T., Stafford L., Supasa P., Tipton T., Turtle L., Tyerman J.K., Whitham R., Wootton D.G.Fuentes:scopusStructural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
ArticleAbstract: The COVID-19 pandemic has had an unprecedented health and economic impact and there are currently noPalabras claves:Autores:Buttigieg K.R., Carrique L., Carroll M.W., Chen C.P., Chen T.H., Cheng C.Y., Cheng S.H., Donat R.F., Duyvesteyn H.M.E., Fry E.E., Godwin K., Huang C.G., Huang K.Y.A., Huang Y.C., Huo J., James W.S., Javier Gilbert Jaramillo, Knight M.L., Lin T.Y., Lin Y.C., Ma C., Malinauskas T., Mongkolsapaya J., Naismith J.H., Owens R.J., Paterson N.G., Radecke J., Ren J., Rijal P., Ruza R.R., Screaton G.R., Shah P.N.M., Shih S.R., Stuart D.I., Supasa P., Tan T.K., Townsend A.R., Tree J.A., Zhao Y., Zhou D.Fuentes:scopusThe antigenic anatomy of SARS-CoV-2 receptor binding domain
ArticleAbstract: Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency use as therapPalabras claves:coronavirus, SARS-CoV-2, anti-RBD antibody, receptor binding domain, antibody, immune responses, virus structureAutores:Bailey A.L., Bertram F.K.R., Bolton J., Carroll M.W., Case J.B., Chen R.E., Clare D.K., Dejnirattisai W., Diamond M.S., Dold C., Dong T., Duyvesteyn H.M.E., Fry E.E., Fyfe A., Ginn H.M., Gupta S., Hall D.R., Howe A., Huang K.Y.A., James W.S., Javier Gilbert Jaramillo, Kafai N.M., Klenerman P., Knight J.C., Knight M.L., Levin R., Liu C., López-Camacho C., Mentzer A.J., Mongkolsapaya J., Paesen G.C., Paterson N.G., Peng Y., Pollard A.J., Radecke J., Ren J., Screaton G.R., Siebert C.A., Skelly D.T., Slon-Campos J., Song Y., Stuart D.I., Supasa P., Tan T.K., Temperton N.J., Thompson C., Townsend A.R., Walter T.S., Wang B., Williams M.A., Ying B., Zhao Y., Zhou D.Fuentes:scopus